$PFE 3 SEC Filings

Filed On	Filing
28 Aug 2026	Form 3: Guegan Cecile, Executive Vice President Holds 149,505 shares of Common Stock
10 Apr 2026	Form 3: Hancock Dennis P, Senior Vice President Holds 45,097 shares of Common Stock
15 Oct 2024	Form 3: Buckley Mortimer J, Director No securities owned
02 Aug 2024	Form 3: Baum Andrew, Executive Vice President No securities owned
01 Jul 2024	Form 3: Taraporevala Cyrus, Director Holds 10,000 shares of Common Stock
21 Dec 2023	Form 3: de Germay Alexandre, Executive Vice President No securities owned
04 Aug 2023	Form 3: Boshoff Christoffel, Executive Vice President Holds 101,554 shares of Common Stock
30 Mar 2023	Form 3: Pfizer Inc, 10% owner · Zura Bio Ltd Holds 2,970,022 shares of Class A Ordinary Shares, $0.0001 par value
29 Dec 2022	Form 3: Pfizer Inc, 10% owner · ORIC Pharmaceuticals, Inc. Holds 5,376,344 shares of Common Stock
13 Oct 2022	Form 3: Pfizer Inc, 10% owner and 1 other · Pyxis Oncology Inc Holds 4,140,669 shares of Common Stock, $0.001 par value per share
09 May 2022	Form 3: Denton David M, Chief Financial Officer & EVP Holds 890 shares of Common Stock
28 Mar 2022	Form 3: Pao William, Executive Vice President No securities owned
10 Jan 2022	Form 3: McDermott Michael, Executive Vice President Holds 66,186 shares of Common Stock
02 Sep 2021	Form 3: Malik Aamir, Executive Vice President Holds 374 shares of Common Stock
15 Dec 2020	Form 3: Pfizer Inc, 10% owner and 1 other · Bioatla Inc
29 Oct 2020	Form 3: Pfizer Inc, 10% owner · Cerevel Therapeutics Holdings, Inc. Holds 26,149,211 shares of Common Stock
06 Aug 2020	Form 3: Pfizer Inc, 10% owner · Viatris Inc. Holds 100 shares of Common Stock, par value $0.01 per share
10 Jul 2020	Form 3: Carapezzi William R Jr, Executive Vice President Holds 42,128 shares of Common Stock
09 Jul 2020	Form 3: Sahni Payal, Executive Vice President Holds 13,393 shares of Common Stock
03 Apr 2020	Form 3: Desmond-Hellmann Susan, Director Holds 3,408 shares of Common Stock

Comments